Nov 6

TOBI Faculty Andrew Ittleman on the FDA’s Regulation of Stem Cells

TOBI 2017 Faculty Andrew Ittleman, JD, has published a valuable article on how the FDA should regulate human cells. This article, which appeared in The Regulatory Review, provides a brief history of the FDA's involvement in the regulation of human cells, starting with the Wall Street Journal Op-ed, "The FDA Wants to Regulate Your Cells", written by Scott Gottlieb in 2012. Gottlieb is now the Commissioner of the FDA. Ittleman analyzes Gottlieb's political history regarding the regulation of human cells,...

May 23

TOBI Faculty Publications: April 2017

Below is a resource of all April 2017 regenerative medicine publications authored by TOBI Speakers and Faculty, including alumni faculty. Each month, we compile a list with links and brief summaries of all new research and studies to keep TOBI community members informed and on the cutting edge of regenerative medicine research. Studies are listed alphabetically by TOBI Faculty names. If you are a TOBI Faculty member or alumni and would like your publications included in the TOBI monthly publications...

May 17

Lyftogt Perineurial Injection Treatment (P.I.T.): Interview with Dr. Steven Sampson

This treatment, first discovered and later further developed by Dr. John Lyftogt, MD, New Zealand, consists of a series of small volume injections of D5W subcutaneously targeting painful superficial nerves (neurogenic pain). D5W (dextrose 5% in sterile water) has a strong safety profile and is used in hospitals for varying indications worldwide. P.I.T. may be an effective treatment for painful conditions due to sport and occupation or other chronic non-malignant pain related issues. It involves first making an accurate diagnosis of the...